Skip to main content

Table 1 Clinical and pathological features of breast cancer patients in the study

From: Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

Variable Number %
Stage (TMN) (n = 341)   
I 124 36.4
II 182 53.4
III 30 8.8
IV 5 1.5
Grade (n = 343)   
1 57 16.6
2 141 41.1
3 145 42.3
Histological type = 347)   
Ductal 219 63.1
Lobular 56 16.1
Mix 35 10.1
Other 37 10.7
Tumor size (n = 346)   
T1 201 58.1
T2 120 34.7
T3 and T4 25 7.2
Nodal status (n = 342)   
Negative 182 53.2
Positive 160 46.8
ER status (n = 342)   
Negative 120 35.1
Positive 222 64.9
PR status (n = 341)   
Negative 163 47.8
Positive 178 52.2
Treatment (n = 348)   
No adjuvant therapy 45 12.9
Chemotherapy 119 34.2
Endotherapy 77 22.1
Chemotherapy and endotherapy 107 30.8